Rosalind Advisors »

Polypid shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Polypid (PYPD) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Polypid

Tip: Access up to 7 years of quarterly data

All positions including Polypid held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Polypid by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 416k 4.60

More positions owned by Rosalind Advisors

Myomo Com New (MYO)
Lyra Therapeutics (LYRA)
Mediwound Shs New (MDWD)
Optinose (OPTN)
Xeris Pharmaceuticals (XERS)
Compass Pathways Sponsored Ads (CMPS)
Cybin Ord (CYBN)
Abivax Sa Sponsored Ads (ABVX)
Miragen Therapeutics (VRDN)
Delcath Systems Com New (DCTH)
Profound Medical Corp Com New (PROF)
Verona Pharma Sponsored Ads (VRNA)
Clearside Biomedical (CLSD)
Outlook Therapeutics Com New
Kalvista Pharmaceuticals (KALV)

View all positions for Rosalind Advisors

Top funds holding Polypid

Rosalind Advisors
Yelin Lapidot Holdings Management
Steward Partners Investment Advisory
UBS Group
Advisor Group Holdings

View all funds holding Polypid